ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Reclassification of Serous Ovarian Carcinoma by a 2-Tier System: A Gynecologic Oncology Group Study
Yearbook of Medicine
◽
10.1016/s0084-3873(12)00204-0
◽
2012
◽
Vol 2012
◽
pp. 140-141
Author(s):
J.T. Thigpen
Keyword(s):
Ovarian Carcinoma
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
System A
◽
Serous Ovarian Carcinoma
◽
Tier System
Download Full-text
Related Documents
Cited By
References
Reclassification of Serous Ovarian Carcinoma by a 2-Tier System: A Gynecologic Oncology Group Study
Yearbook of Oncology
◽
10.1016/j.yonc.2012.08.026
◽
2012
◽
Vol 2012
◽
pp. 119-120
Author(s):
J.T. Thigpen
Keyword(s):
Ovarian Carcinoma
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
System A
◽
Serous Ovarian Carcinoma
◽
Tier System
Download Full-text
The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1)
Gynecologic Oncology
◽
10.1016/j.ygyno.2019.02.010
◽
2019
◽
Vol 153
(2)
◽
pp. 312-319
Author(s):
Ryusuke Murakami
◽
Noriomi Matsumura
◽
Hirofumi Michimae
◽
Hiroshi Tanabe
◽
Mayu Yunokawa
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
High Grade
◽
Oncology Group
◽
Oncology Group Study
◽
Mesenchymal Transition
◽
Serous Ovarian Carcinoma
◽
Dose Dense
◽
Taxane Chemotherapy
Download Full-text
The prognostic significance of pre and post-treatment CA-125 levels in low grade serous ovarian carcinoma: A Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/j.ygyno.2011.12.081
◽
2012
◽
Vol 125
◽
pp. S35-S36
Author(s):
A. Nickles Fader
◽
J. Java
◽
A. Tergas
◽
T. Krivak
◽
R. Bristow
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Gynecologic Oncology
◽
Prognostic Significance
◽
Post Treatment
◽
Ca 125
◽
Low Grade
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Serous Ovarian Carcinoma
Download Full-text
Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma—a Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1016/s0090-8258(03)00068-4
◽
2003
◽
Vol 89
(1)
◽
pp. 148-154
◽
Cited By ~ 51
Author(s):
Jeffrey D Bloss
◽
Mark F Brady
◽
Shu Yuan Liao
◽
Thomas Rocereto
◽
Edward E Partridge
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Papillary Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Serous Ovarian Carcinoma
◽
Serous Papillary Carcinoma
Download Full-text
The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/j.ygyno.2013.11.016
◽
2014
◽
Vol 132
(3)
◽
pp. 560-565
◽
Cited By ~ 27
Author(s):
Amanda Nickles Fader
◽
James Java
◽
Thomas C. Krivak
◽
Robert E. Bristow
◽
Ana I. Tergas
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Gynecologic Oncology
◽
Prognostic Significance
◽
Post Treatment
◽
Ca 125
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Serous Ovarian Carcinoma
Download Full-text
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
Gynecologic Oncology
◽
10.1016/j.ygyno.2018.05.029
◽
2018
◽
Vol 150
(2)
◽
pp. 247-252
◽
Cited By ~ 18
Author(s):
John K. Chan
◽
William Brady
◽
Bradley J. Monk
◽
Jubilee Brown
◽
Mark S. Shahin
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Clear Cell
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Clear Cell Ovarian Carcinoma
Download Full-text
Optimal cytoreductive surgery to microscopic residual improves survival in women with low grade serous ovarian carcinoma: A Gynecologic Oncology Group ancillary study
Gynecologic Oncology
◽
10.1016/j.ygyno.2011.12.029
◽
2012
◽
Vol 125
◽
pp. S12-S13
Author(s):
A. Nickles Fader
◽
J. Java
◽
S. Ueda
◽
M. Bookman
◽
R. Bristow
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Cytoreductive Surgery
◽
Gynecologic Oncology
◽
Low Grade
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Ancillary Study
◽
Serous Ovarian Carcinoma
Download Full-text
Response to Dr. Markman's letter “Re: ‘Randomized phase III trial of three versus six cycles of carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study’”
Gynecologic Oncology
◽
10.1016/j.ygyno.2007.01.007
◽
2007
◽
Vol 105
(1)
◽
pp. 280-281
Author(s):
J BELL
Keyword(s):
Ovarian Carcinoma
◽
Early Stage
◽
Gynecologic Oncology
◽
Epithelial Ovarian Carcinoma
◽
Phase Iii
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Phase Iii Trial
◽
Oncology Group Study
Download Full-text
Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1006/gyno.1999.5532
◽
1999
◽
Vol 75
(1)
◽
pp. 10-14
◽
Cited By ~ 48
Author(s):
Jonathan S. Berek
◽
Maurie Markman
◽
Bette Stonebraker
◽
Samuel S. Lentz
◽
Mark D. Adelson
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Gynecologic Oncology
◽
Interferon Α
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second-line therapy in 105 patients
Cancer
◽
10.1002/1097-0142(19910715)68:2<269::aid-cncr2820680209>3.0.co;2-o
◽
1991
◽
Vol 68
(2)
◽
pp. 269-271
◽
Cited By ~ 140
Author(s):
Kenneth D. Hatch
◽
Jackson B. Beecham
◽
John A. Blessing
◽
William T. Creasman
Keyword(s):
Ovarian Carcinoma
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Second Line
◽
Oncology Group
◽
Second Line Therapy
◽
Oncology Group Study
◽
Advanced Ovarian Carcinoma
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close